Streetbeat News

Analyst Ratings

HUM

A significant bullish stance has been taken on Humana (NYSE:HUM) by a large investor or institution, as evidenced by unusual options activity. The sentiment among these big-money traders is 67% bullish and 32% bearish. The targeted price range for Humana over the last 3 months has been $360.0 to $520.0. Analysts from Mizuho, UBS, Wells Fargo, and Morgan Stanley maintain a Buy or Overweight rating on Humana, while JP Morgan has downgraded its action to Neutral.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:46 pm

JPM

A significant investor has taken a bearish stance on JPMorgan Chase (NYSE:JPM), with 55% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $135.0 to $185.0 for JPMorgan Chase over the last 3 months. The price of JPM is up 0.26% at $157.31, and RSI indicators suggest that the stock may be overbought. The next earnings are expected to be released in 74 days.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:32 pm

MDB

A significant amount of unusual options activity has been observed for MongoDB (NASDAQ:MDB), with a majority of investors taking a bullish stance. The price range targeted by these investors over the last 3 months is from $175.0 to $630.0. Currently, the price of MDB is up 2.75% at $422.93. JMP Securities and Keybanc have maintained their Outperform and Overweight ratings on MongoDB, respectively, with price targets of $425 and $462.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:32 pm

FDX

A significant investor has taken a bullish stance on FedEx (NYSE:FDX), with 50% of the investors opening trades with bullish expectations and 50% with bearish. The trades include 7 puts, totaling $347,180, and 5 calls, totaling $157,985. The price target range for FedEx over the last 3 months has been $200.0 to $290.0. The price of FDX is up 0.14% at $269.23, and RSI indicators suggest the stock may be approaching overbought.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:15 pm

BAH

Truist Securities analyst Tobey Sommer has reiterated a Hold rating on Booz Allen Hamilton Holding Corporation (NYSE:BAH), raising the price target to $120 from $106. The company reported Q1 revenue growth of 18% YoY to $2.65 billion, beating the consensus of $2.51 billion. Sommer believes BAH is viewed as a relative AI leader in the Government Services space and estimates AI revenues of ~$400 million today, growing at a ~20% CAGR over the past five years.

Portfolio Pulse from Nabaparna Bhattacharya

July 31, 2023 | 6:13 pm

AAWH

AYRWF

CCHWF

GTBIF

JUSHF

PLNHF

SHWZ

TCNNF

TRSSF

Analysts expect 2nd quarter EBITDA margins to be higher than 1st quarter for nine out of fourteen major cannabis companies. However, most companies are expected to have lower Q2 23 EBITDA margins than Q2 22 due to wholesale pricing pressures and inflation-driven cost increases. Outliers include Planet 13, Ascend, Trulieve, Green Thumb, and Schwazze, which are facing various challenges. Jushi, Columbia Care, Terrascend, and AYR have higher expectations due to various improvements and strategies.

Portfolio Pulse from Viridian Capital Advisors

July 31, 2023 | 6:07 pm

TROW

T. Rowe Price Gr (NASDAQ:TROW) has received 9 analyst ratings in the last quarter, with 5 being indifferent and 4 bearish. The average price target is $105.89, which is lower than the current price of $125.285, implying a downside. The average price target has increased by 2.87% from the previous target of $102.94.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:01 pm

HUBG

Over the past 3 months, 7 analysts have published their opinion on Hub Group (NASDAQ:HUBG) stock. The company has an average price target of $91.86, an increase of 1.42% from the previous average price target of $90.57. The majority of the analysts are indifferent about the stock, with one analyst each giving bullish and somewhat bullish ratings.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:01 pm

CC

Analysts have provided various ratings for Chemours (NYSE:CC) within the last quarter, with 1 bullish, 1 somewhat bullish, and 6 indifferent. The average price target is $40.5, implying an upside from the current price of $36.39. This average price target has increased by 2.84% over the past month.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:01 pm

WDAY

In the last quarter, Workday (NASDAQ:WDAY) received 7 bullish, 13 somewhat bullish, and 4 indifferent ratings from analysts. The company's average 12-month price target is $240.08, a 9.85% increase from the previous average of $218.55. No bearish or somewhat bearish ratings were observed.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:00 pm